Endometrial hyperplasia generally refers to endometrial hyperplasia, but clinically there is no endometrial hyperplasia what to eat in order to completely eradicate the statement, patients in the standardization of drug treatment, can achieve clinical cure, but there is a risk of recurrence, if necessary, also need to carry out surgical treatment. Patients with endometrial hyperplasia not accompanied by atypical hyperplasia have a lower risk of developing endometrioid carcinoma, generally less than 5%, and most of them can be reversed or even returned to normal after standardized drug treatment. However, due to the risk of recurrence and malignant changes, patients can only achieve clinical cure and need to be rechecked on a regular basis. Usually, if the endometrial hyperplasia is not accompanied by atypical endometrial hyperplasia, the patient can follow the doctor’s instructions to take oral progestin medication such as medroxyprogesterone, dydrogesterone, etc., and also with the placement of levonorgestrel intrauterine system. In contrast, patients with atypical endometrial hyperplasia can be treated with progestin medications such as medroxyprogesterone acetate and medroxyprogesterone acetate as prescribed by the doctor. If the patient’s medication is ineffective, or if there is persistent abnormal uterine bleeding, then laparoscopic or transabdominal surgery is also required under the supervision of the doctor. It is recommended that patients with endometrial hyperplasia follow the doctor’s instructions for systematic treatment in a timely manner and take good care of themselves to stabilize their condition.